| TCERG1 |
TCERG1, CA150, TAF2S: Transcription elongation regulator 1 |
MATR3 |
MATR3, KIAA0723: Matrin-3 |
0.255 |
Evidence |
|
| TCERG1 |
TCERG1, CA150, TAF2S: Transcription elongation regulator 1 |
RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
0.255 |
Evidence |
|
| ADAM10 |
ADAM10, KUZ, MADM: ADAM 10 precursor |
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
0.255 |
Evidence |
|
| TRIM38 |
TRIM38, RNF15, RORET: Tripartite motif-containing protein 38 |
USP3 |
USP3: Ubiquitin carboxyl-terminal hydrolase 3 |
0.255 |
Evidence |
|
| TRIM38 |
TRIM38, RNF15, RORET: Tripartite motif-containing protein 38 |
KLF2 |
KLF2, LKLF: Krueppel-like factor 2 |
0.255 |
Evidence |
|
| TRIM38 |
TRIM38, RNF15, RORET: Tripartite motif-containing protein 38 |
ZNF394 |
ZNF394, ZKSCAN14: Zinc finger protein 394 |
0.255 |
Evidence |
|
| TRIM38 |
TRIM38, RNF15, RORET: Tripartite motif-containing protein 38 |
CASP4 |
CASP4, ICH2: Caspase-4 precursor |
0.255 |
Evidence |
|
| TRIM38 |
TRIM38, RNF15, RORET: Tripartite motif-containing protein 38 |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
0.255 |
Evidence |
|
| CYR61 |
CYR61, CCN1, GIG1, IGFBP10: Protein CYR61 precursor |
COL1A2 |
IPI00164755 |
0.255 |
Evidence |
|
| CYR61 |
CYR61, CCN1, GIG1, IGFBP10: Protein CYR61 precursor |
COL5A2 |
IPI00293881 |
0.255 |
Evidence |
|
| CYR61 |
CYR61, CCN1, GIG1, IGFBP10: Protein CYR61 precursor |
SRPX |
SRPX, ETX1: Sushi repeat-containing protein SRPX precursor |
0.255 |
Evidence |
|
| CYR61 |
CYR61, CCN1, GIG1, IGFBP10: Protein CYR61 precursor |
COL5A1 |
IPI00303313 |
0.255 |
Evidence |
|
| FCN1 |
FCN1, FCNM: Ficolin-1 precursor |
CD93 |
CD93, C1QR1, MXRA4: Complement component C1q receptor precursor |
0.255 |
Evidence |
|
| FCN1 |
FCN1, FCNM: Ficolin-1 precursor |
CSPG2 |
IPI00009802 |
0.255 |
Evidence |
|
| FCN1 |
FCN1, FCNM: Ficolin-1 precursor |
LGALS2 |
LGALS2: Galectin-2 |
0.255 |
Evidence |
|
| PES1 |
PES1: Pescadillo homolog 1 |
XRCC6 |
XRCC6, G22P1: ATP-dependent DNA helicase 2 subunit 1 |
0.255 |
Evidence |
|
| HMGN4 |
HMGN4, HMG17L3, NHC: High mobility group nucleosome-binding domain-containing pr |
HNRPDL |
IPI00011274 |
0.255 |
Evidence |
|
| HMGN4 |
HMGN4, HMG17L3, NHC: High mobility group nucleosome-binding domain-containing pr |
STK10 |
STK10: Uncharacterized protein STK10 |
0.255 |
Evidence |
|
| HMGN4 |
HMGN4, HMG17L3, NHC: High mobility group nucleosome-binding domain-containing pr |
RP6-213H19.1 |
MST4, MASK: Serine/threonine-protein kinase MST4 |
0.255 |
Evidence |
|
| HMGN4 |
HMGN4, HMG17L3, NHC: High mobility group nucleosome-binding domain-containing pr |
TAOK3 |
TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 |
0.255 |
Evidence |
|
| HMGN4 |
HMGN4, HMG17L3, NHC: High mobility group nucleosome-binding domain-containing pr |
PRKD2 |
PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 |
0.255 |
Evidence |
|
| HMGN4 |
HMGN4, HMG17L3, NHC: High mobility group nucleosome-binding domain-containing pr |
RBM15 |
RBM15, OTT: Putative RNA-binding protein 15 |
0.255 |
Evidence |
|
| HMGN4 |
HMGN4, HMG17L3, NHC: High mobility group nucleosome-binding domain-containing pr |
RBM3 |
RBM3, RNPL: Putative RNA-binding protein 3 |
0.255 |
Evidence |
|
| HMGN4 |
HMGN4, HMG17L3, NHC: High mobility group nucleosome-binding domain-containing pr |
CSNK1G2 |
CSNK1G2: Casein kinase I isoform gamma-2 |
0.255 |
Evidence |
|
| HMGN4 |
HMGN4, HMG17L3, NHC: High mobility group nucleosome-binding domain-containing pr |
CDK9 |
CDK9, CDC2L4: Cell division protein kinase 9 |
0.255 |
Evidence |
|